Literature DB >> 492146

Voltage-dependent and voltage-independent blockade of acetylcholine receptors by local anesthetics in Electrophorus electroplaques.

D D Koblin, H A Lester.   

Abstract

Mesh:

Substances:

Year:  1979        PMID: 492146

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  8 in total

1.  Conformation of acetylcholine receptor in the presence of agonists and antagonists.

Authors:  C S Wu; X H Sun; J T Yang
Journal:  J Protein Chem       Date:  1990-02

Review 2.  Acetylcholine receptor kinetics: chemical kinetics.

Authors:  J B Udgaonkar; G P Hess
Journal:  J Membr Biol       Date:  1986       Impact factor: 1.843

Review 3.  Acetylcholine receptor kinetics.

Authors:  P R Adams
Journal:  J Membr Biol       Date:  1981-02-28       Impact factor: 1.843

4.  Inhibition of the nicotinic acetylcholine receptor by barbiturates and by procaine: do they act at different sites?

Authors:  C S Yost; B A Dodson
Journal:  Cell Mol Neurobiol       Date:  1993-04       Impact factor: 5.046

5.  Procaine alters fast excitatory postsynaptic current decay in amphibian sympathetic ganglia.

Authors:  E A Connor; R L Parsons
Journal:  Br J Pharmacol       Date:  1983-02       Impact factor: 8.739

6.  Effects of chlorpromazine and phencyclidine on mouse C2 acetylcholine receptor kinetics.

Authors:  J P Changeux; C Pinset; A B Ribera
Journal:  J Physiol       Date:  1986-09       Impact factor: 5.182

7.  A covalently bound photoisomerizable agonist: comparison with reversibly bound agonists at Electrophorus electroplaques.

Authors:  H A Lester; M E Krouse; M M Nass; N H Wassermann; B F Erlanger
Journal:  J Gen Physiol       Date:  1980-02       Impact factor: 4.086

8.  Mechanisms Underlying the Strong Inhibition of Muscle-Type Nicotinic Receptors by Tetracaine.

Authors:  Raúl Cobo; Magdalena Nikolaeva; Armando Alberola-Die; Gregorio Fernández-Ballester; José M González-Ros; Isabel Ivorra; Andrés Morales
Journal:  Front Mol Neurosci       Date:  2018-08-08       Impact factor: 5.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.